Barclays Downgrades Amag Pharmaceuticals After 130% Rally From Lows
August 18, 2020 at 08:33 AM EDT
Barclays analyst Balaji Prasad downgraded Amag Pharmaceuticals to Equal Weight from Overweight with an unchanged price target of $10.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|